Catherine Thieblemont

Catherine Thieblemont

UNVERIFIED PROFILE

Are you Catherine Thieblemont?   Register this Author

Register author
Catherine Thieblemont

Catherine Thieblemont

Publications by authors named "Catherine Thieblemont"

Are you Catherine Thieblemont?   Register this Author

100Publications

4377Reads

18Profile Views

Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients.

Cancer Immunol Immunother 2019 Sep 7. Epub 2019 Sep 7.

Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Inserm UMRS 1138, "Cancer, Immune Control and Escape" Laboratory, Centre de Recherche des Cordeliers, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02389-7DOI Listing
September 2019

Specific renal infiltration by aggressive lymphoma mimicking tumor lysis syndrome.

Intensive Care Med 2019 Aug 26. Epub 2019 Aug 26.

Medical ICU, AP-HP, Saint Louis Hospital, Paris-7 Paris-Diderot University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00134-019-05759-yDOI Listing
August 2019

Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.

Health Qual Life Outcomes 2019 Jul 2;17(1):115. Epub 2019 Jul 2.

Centre de Traitement des Données du Cancéropôle Nord-Ouest, Plateforme de Recherche Clinique Ligue Contre le Cancer, Centre François Baclesse, 3 Avenue Général Harris, 14076, Caen, Cedex 5, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12955-019-1186-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604328PMC
July 2019

Intensive care unit admission in patients with T cell lymphomas: clinical features and outcome.

Ann Hematol 2019 Jan 14;98(1):195-203. Epub 2018 Sep 14.

Medical Intensive Care Unit, AP-HP, Saint-Louis University Hospital, 1 avenue Claude Vellefaux, 75010, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-018-3496-1
Publisher Site
http://dx.doi.org/10.1007/s00277-018-3496-1DOI Listing
January 2019

Burden of illness of follicular lymphoma and marginal zone lymphoma.

Ann Hematol 2019 Jan 13;98(1):175-183. Epub 2018 Oct 13.

APHP, Hemato-Oncology, Hôpital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-018-3501-8
Publisher Site
http://dx.doi.org/10.1007/s00277-018-3501-8DOI Listing
January 2019

Curing diffuse large B-cell lymphomas in elderly patients.

Eur J Intern Med 2018 12 22;58:14-21. Epub 2018 Nov 22.

Hemato-Oncology Department, Diderot University, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, Paris 75010, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2018.10.003DOI Listing
December 2018

L’arrivée de l’immunothérapie dans le lymphome de Hodgkin.

Bull Cancer 2018 Dec;105 Suppl 1:S50-S58

Service d'onco-hématologie - Hôpital Saint-Louis, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(18)30390-4DOI Listing
December 2018

Cerebrospinal fluid interleukin (IL)-10 and IL-10:IL-6 ratio as biomarkers for small B-cell lymphoproliferations with leptomeningeal dissemination.

Semin Hematol 2018 10 6;55(4):179-181. Epub 2017 Jul 6.

Department of Biological Hematology, Pitie-Salpetriere Hospital, Paris, France; Centre de Recherche des Cordeliers, Cell Death and Drug Resistance in Lymphoproliferative Disorders, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2017.06.005DOI Listing
October 2018

Optimizing initial therapy in DLBCL.

Best Pract Res Clin Haematol 2018 09 7;31(3):199-208. Epub 2018 Aug 7.

EA7324, Descartes University, 4 Avenue de l'Observatoire, 75006, Paris, France; APHP, Pathology, Necker Hospital, 149 Rue de Sèvres, 75015, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2018.08.001DOI Listing
September 2018

Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphoma.

Hematology Am Soc Hematol Educ Program 2017 12;2017(1):371-378

Hemato-Oncology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France; Diderot University, Sorbonne Paris-Cité, Paris, France; and EA7324, Descartes University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2017.1.371DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142593PMC
December 2017

Tailoring treatment for MALT lymphoma patients: where do we stand now?

Oncotarget 2017 Dec 6;8(70):114422-114423. Epub 2017 Dec 6.

International Extranodal Lymphoma Study Group (IELSG), Foundation for the Research and Cure of Lymphoma in Ticino, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.23001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777700PMC
December 2017

Clinical aspects and therapy of gastrointestinal MALT lymphoma.

Best Pract Res Clin Haematol 2017 Mar - Jun;30(1-2):109-117. Epub 2017 Jan 30.

Lymphoma Unit, Division of Research, Oncology Institute of Southern Switzerland (IOSI), Ospedale San Giovanni, 6500 Bellinzona, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2017.01.002DOI Listing
October 2017

Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients.

Oncotarget 2017 Oct 6;8(45):80073-80082. Epub 2017 Sep 6.

Department of Onco-Hematology, Hôpital Saint Louis, Assistance Publique des Hôpitaux de Paris (AP-HP), Université Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.20684DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668122PMC
October 2017

A MALT lymphoma prognostic index.

Blood 2017 09 18;130(12):1409-1417. Epub 2017 Jul 18.

Lymphoma Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-03-771915DOI Listing
September 2017

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

N Engl J Med 2017 09;377(13):1250-1260

From Service d'Hématologie Clinique (S.L.G., T.G.), Service d'Anatomopathologie (A.M.), and Service d'Hématologie Biologique (M.C.B.), Hôtel-Dieu Centre Hospitalier Universitaire (CHU) de Nantes, and Centre de Recherche en Cancérologie et Immunologie (S.L.G., M.C.B.) and Faculté de Médecine (S.L.G.), Université de Nantes, Nantes, Hemato-Oncologie, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Université Diderot Sorbonne Paris-Cité (C.T.), Université Descartes (C.T.), Département d'Hématologie, Faculté de Médecine, Université Paris-Sud (V.R.), Département d'Anatomopathologie (D.C.) and Département d'Hématologie (O.H.), Necker Hospital, APHP, Sorbonne Paris-Cité, and INSERM Unité 1163 et Centre National de la Recherche Scientifique (CNRS) Équipe de Recherche Labellisée 8654, Imagine Institute (O.H.), Paris, Département d'Hématologie, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse (L.O.), Service d'Hématologie Clinique et Thérapie Cellulaire, CHU de Bordeaux, Bordeaux (K.B.), Service d'Hématologie et Thérapie Cellulaire, CHU de Tours, Tours (C.D.), Service d'Hématologie, CHU d'Amiens, Amiens (G.D.), INSERM, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif (V.R.), Département d'Hématologie, CHU de Nancy, Nancy (P.F.), INSERM Unité 954, Vandoeuvre (P.F.), Service d'Hématologie Clinique, CHU de Dijon, and INSERM Unité Mixte de Recherche 1231, Dijon (O.C.), Service d'Hématologie, Centre Hospitalier d'Avignon, Avignon (H.Z.), Lymphoid Malignancies Unit, Hôpital Henri Mondor, APHP, Créteil (C.H.), Service d'Hématologie du Centre Hospitalier de Vendée, La Roche-sur-Yon (H.M.), Service Hématologie Clinique (R.H.) and Département d'Hématologie (T.L.), CHU de Rennes, INSERM Unité 917 (R.H.), and INSERM Unité 1236 (T.L.), Rennes, Département d'Hematology, Centre Henri-Becquerel et Université de Normandie Unité 1245, Rouen (F.J., H.T.), Service d'Hématologie Clinique Adulte et de Thérapie Cellulaire, CHU de Clermont-Ferrand et Université Clermont Auvergne, Clermont-Ferrand (O.T.), Service d'Hématologie, Clinique Victor Hugo, Le Mans (K.L.D.), Department of Hematology, Université de Lille, Groupe de Recherche sur les Formes Injectables et les Technologies Associées, and CHU de Lille, Lille (F.M.), Département d'Hématologie Clinique, CHU de Montpellier, CNRS UMR 5235, Montpellier (G.C.), Service d'Oncologie et d'Hématologie, Hôpitaux Universitaires de Strasbourg, Strasbourg (L.-M.F.), INSERM 1209, CNRS UMR 5309, Faculté de Médecine, Université Grenoble Alpes (M.C., R.G.), Institute for Advanced Biosciences (M.C.), and Laboratoire de Génétique Onco-hématologie (M.C.) and Faculté de Médecine (R.G.), CHU de Grenoble Alpes, Grenoble, Service d'Hématologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite (G.S.), and Université Claude Bernard Lyon 1 and Cancer Research Center of Lyon, INSERM 1052 CNRS 5286 Lyon, Lyon (G.S.) - all in France; and Département d'Hématologie, Cliniques Universitaires Saint-Luc-Université Catholique de Louvain, Brussels (E.V.D.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1701769DOI Listing
September 2017

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

J Clin Oncol 2017 Aug 20;35(22):2473-2481. Epub 2017 Apr 20.

Catherine Thieblemont, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis; Diderot University, Sorbonne Paris-Cité; Catherine Thieblemont and Josette Briere, Descartes University; Josette Briere, Hôpital Necker, Paris; Hervé Tilly, University of Rouen, Institut National de la Santé et de la Recherche Médicale U1245, Rouen; Rene-Olivier Casasnovas, Centre Hospitalier Universitaire Dijon; Institut National de la Santé et de la Recherche Médicale UMR1231, Dijon; Christophe Fruchart, Institut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire, Caen; Franck Morschhauser, Centre Hospitalier Universitaire Régional de Lille, Lille; Corinne Haioun and Philippe Gaulard, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Mondor; Philippe Gaulard, Institut National de la Santé et de la Recherche Médicale U955; Université Paris-Est, Créteil; Julien Lazarovici, Gustave Roussy Cancer Center, Villejuif; Aurore Perrot, University Hospital, Vandoeuvre les Nancy; Catherine Sebban, Centre Leon Berard, University Claude Bernard Lyon 1; Gilles Salles, Hospices Civils de Lyon, Université Claude Bernard U1052, Lyon; Hugo Gonzalez, Centre Hospitalier René Dubos, Pontoise; Reda Bouabdallah, Institut Paoli Calmettes, Marseille; Lucie Oberic, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse; Bernadette Corront, Centre Hospitalier Régional Annecy, Annecy; Bachra Choufi, Centre Hospitalier Dr Duchenne, Boulogne-sur-mer; Gilles Salles and Bertrand Coiffier, Institut National de la Santé et de la Recherche Médicale U1052, Hospices Civils de Lyon, Pierre-Benite, France; Maria Gomes da Silva and Jose Cabeçadas, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal; Anida Grosicka, Medical University of Silesia, Katowice, Poland; Judith Trotman, Concord Repatriation General Hospital, University of Sydney, Concord; John Catalano, Frankston Hospital and Monash University, Frankston, Australia; Dolores Caballero, Hospital Universitario de Salamanca, Salamanca; Armando Lopez-Guillermo, Hospital Clinic Barcelona, Barcelona, Spain; Richard Greil, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute; Arbeitsgemeinschaft Medikamentöse Tumortherapie, Salzburg, Austria; Koen van Eygen, Algemeen Ziekenhuis Groeninge Hospital, President Kennedylaan 4, Kortrijk; Achiel Van Hoof, Algemeen Ziekenhuis Sint Jan AV, Brugge; Andre Bosly, UCL Mont Godinne, Yvoir, Belgium; and Amos M. Cohen, Rabin Medical Center, Beilinson Hospital, Davidoff Cancer Center, Tel-Aviv University, Ramat-Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6984DOI Listing
August 2017

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

J Clin Oncol 2017 Jun 29;35(17):1905-1912. Epub 2017 Mar 29.

Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andrés J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia; Umberto Vitolo, University-Hospital Città della Salute e della Scienza, Turin; Maurizio Martelli, Sapienza University; Stefan Hohaus, Catholic University of the Sacred Heart, Rome; Graziella Pinotti, Fondazione Macchi Hospital, Varese; Caterina Stelitano, Bianchi-Melacrino-Morelli Hospitals, Reggio Calabria; Monica Bellei, University of Modena and Reggio Emilia, Modena, Italy; Reda Bouabdallah, Institut Paoli-Calmettes, Marseille; Gilles Salles, Hospices Civils de Lyon and Université Claude Bernard Lyon-1, Pierre-Benite; Catherine Sebban, Centre Léon Bérard, Lyon; Franck Morschhauser, Claude Huriez Hospital, Lille; Anne Moreau, University Hospital of Nantes, Nantes; Hervé Tilly, Centre Henri Becquerel, Rouen; Corinne Haioun, Henri-Mondor Hospital, Paris Créteil; Corinne Haioun, UPEC, Assistance Publique-Hopitaux de Paris; Catherine Thieblemont, Assistance Publique-Hopitaux de Paris, Hôpital-Saint-Louis, Hematooncology-Université Paris Diderot, Sorbonne Paris-Cité, Paris, France; Ruth Pettengell, St George's University of London, London; Andrew Jack, St James's University Hospital, Leeds; Peter Johnson, Southampton General Hospital, Southampton, United Kingdom; Armando Lopez Guillermo and Elias Campo, Hospital Clinic, Barcelona, Spain; Pierre Zachée, ZNA Stuivenberg, Antwerp; and André Bosly, Mont-Godinne UCL, Yvoir, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.6994DOI Listing
June 2017

Management of aggressive lymphoma in very elderly patients.

Hematol Oncol 2017 Jun;35 Suppl 1:49-53

EA7324, Descartes University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2413DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873382PMC
June 2017

Development and Validation of a Simultaneous Quantification Method of 14 Tyrosine Kinase Inhibitors in Human Plasma Using LC-MS/MS.

Ther Drug Monit 2017 02;39(1):43-54

Departments of *Pharmacology and †Pharmacy, AP-HP, Hôpital Saint-Louis; ‡INSERM UMR_S976, Université Paris-Diderot, Sorbonne Paris Cité; and Departments of §Dermatology and ¶Hematology, AP-HP, Hôpital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0000000000000357DOI Listing
February 2017

Rituximab-ABV(D) for patients with Nodular lymphocyte predominant Hodgkin lymphoma ineligible for radiation therapy.

Br J Haematol 2016 11 18;175(4):735-737. Epub 2015 Dec 18.

Department of Haematology, APHP, Hôpital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13879DOI Listing
November 2016

Pulmonary mucosa-associated lymphoid tissue lymphoma revisited.

Eur Respir J 2016 10;48(4):1252

Service de Pneumologie, Centre de compétences maladies pulmonaires rares, AP-HP, Hôpital Tenon, Paris, France GRC-THERANOSCAN, Université P&M Curie, Université Paris 6, Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01143-2016DOI Listing
October 2016

Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma.

Leuk Lymphoma 2015 12;56(11):3090-5. Epub 2015 May 12.

a Medical Intensive Care Unit, Saint Louis University Hospital , Paris , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1034700DOI Listing
September 2016

Pulmonary mucosa-associated lymphoid tissue lymphoma revisited.

Eur Respir J 2016 Apr 21;47(4):1244-60. Epub 2016 Jan 21.

Service de Pneumologie, Centre de compétences maladies pulmonaires rares, AP-HP, Hôpital Tenon, Paris, France GRC-THERANOSCAN, Université P&M Curie, Université Paris 6, Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01701-2015DOI Listing
April 2016

Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.

J Clin Oncol 2016 Apr 29;34(12):1386-94. Epub 2016 Feb 29.

Eva Hoster, Roswitha Forstpointner, Christian Schmidt, Wolfgang Hiddemann, Michael Unterhalt, and Martin H. Dreyling, University Hospital Munich; Eva Hoster, University of Munich, Munich; Andreas Rosenwald, University of Würzburg, Würzburg; Heinz-Wolfram Bernd, University Hospital Schleswig-Holstein, Lübeck; Sylvia Hartmann, University Hospital of Frankfurt, Frankfurt am Main; Christoph Loddenkemper, University Hospital Berlin Charité; Christoph Loddenkemper, Pathologie PathoTres, Berlin; Thomas F.E. Barth, University Medical Center Ulm; Stephan Stilgenbauer, University of Ulm, Ulm; Michael Hallek, Universität zu Köln, Köln; Ursula Vehling-Kaiser, Tagesklinik Hämatologie Onkologie, Landshut; Lothar Kanz, University of Tübingen, Tübingen; Michael Pfreundschuh, Universitätsklinik des Saarlandes, Homburg; Wolfram Klapper, University of Kiel, Kiel, Germany; Françoise Berger, LYSA Group; Nicole Brousse, Hopital Necker; Catherine Thieblemont, Hôpital Saint Louis; Olivier Hermine, University Paris Descartes; Olivier Hermine, Université Sorbonne Paris Cité, Paris; Bertrand Coiffier, Centre Hospitalier Lyon-Sud, Pierre-Bénite; Réda Bouabdallah, Service d'Hématologie, Marseille; Vincent Ribrag, Institut Gustave Roussy, Villejuif, France; Stefano Pileri, University of Bologna, Bologna, Italy; Grzegorz Rymkiewicz, The Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Roman Kodet, Charles University, Prague, Czech Republic; and Johanna C. Kluin-Nelemans, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.8387DOI Listing
April 2016

Optimizing therapy for nodal marginal zone lymphoma.

Blood 2016 04 17;127(17):2064-71. Epub 2016 Mar 17.

Hématologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France; and UMR_S 1138, Université Pierre et Marie Curie, Paris, France.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/content/early/2016/03/17/blood-2
Web Search
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2015-12-62
Publisher Site
http://dx.doi.org/10.1182/blood-2015-12-624296DOI Listing
April 2016

Liposomal cytarabine in prophylaxis or curative treatment of central nervous system involvement in Burkitt leukemia/lymphoma.

Ann Hematol 2015 Nov 18;94(11):1859-63. Epub 2015 Aug 18.

Adult Hematology Department, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2475-zDOI Listing
November 2015

Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse.

Blood 2015 Oct 3;126(14):1695-8. Epub 2015 Aug 3.

Hemato-oncology Department, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Paris, France; Paris Diderot Université, Sorbonne Paris Cité, Paris, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-05-647834DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591793PMC
October 2015

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41).

Oncologist 2015 Oct 12;20(10):1149-53. Epub 2015 Aug 12.

Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota USA; Hospital of Bolzano, Department of Hematology & Center of Bone Marrow Transplantation, Bolzano, Italy; Department of Hematology and Oncology, University Hospital Innsbruck, Innsbruck, Austria; University Hospital of Crete, Heraklion, Greece; Athens Medical Center-Psychikon Branch, Athens, Greece; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Hematology Unit, Department of Internal Medicine, Ospedale degli Infermi, Biella, Italy; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy; Hospital Clínic, Hematology, Barcelona, Spain; Cancer Research UK Centre, Southampton, United Kingdom; Dipartimento Biotecnologie Cellulari ed Ematologia, Universitá La Sapienza, Rome, Italy; European Institute of Oncology, Division of Clinical Haemato-Oncology, Milan, Italy; APHP, Saint-Louis Hospital, Hemato-Oncology, and Diderot University-Sorbonne Paris Cité, Paris, France; Département de Pathologie, Groupe Henri Mondor-Albert Chenevier, AP-HP, Creteil, France; Diagnostic Haematopathology, European Institute of Oncology, Milan, Bologna University School of Medicine, Bologna, Italy; St. James's University Hospital, Leeds, United Kingdom; Hospital Clinic, Anatomia Patologica, IDIBAPS, Barcelona, Spain; ICP Locarno, Locarno, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591947PMC
October 2015

PET2 -driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP.

Br J Haematol 2015 Jul 9;170(2):278-81. Epub 2015 Jan 9.

Department of Haematology, Hôpital Saint Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13287DOI Listing
July 2015

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.

Blood 2015 Jul 28;126(5):604-11. Epub 2015 May 28.

Department of Internal Medicine III, University Hospital Munich, Munich, Germany; Department of Medical Informatics, Biometry, and Epidemiology, University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-02-628792DOI Listing
July 2015

Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma.

Int J Cancer 2015 Jun 3;136(12):2761-74. Epub 2014 Dec 3.

U978 Institut National de la Santé et de la Recherche Médicale, Bobigny, France; Labex Inflamex, Université Paris 13, Sorbonne Paris Cité, Bobigny, France; Service d'Hématologie Biologique, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29326DOI Listing
June 2015

[Ibrutinib: A new drug of B-cell malignancies].

Bull Cancer 2015 Jun;102(6 Suppl 1):S85-90

Service d'hémato-oncologie, Hôpital Saint-Louis (AP-HP), Université Paris Diderot, Sorbonne Paris Cité, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(15)31222-4DOI Listing
June 2015

Rituximab therapy for hairy cell leukemia: a retrospective study of 41 cases.

Ann Hematol 2015 Jan 7;94(1):89-95. Epub 2014 Sep 7.

Centre Hospitalier Universitaire (CHU) de Reims, Hôpital Robert Debré, Service d'Hématologie Clinique, Reims, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2175-0DOI Listing
January 2015

Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.

J Clin Oncol 2014 Dec 10;32(35):3996-4003. Epub 2014 Nov 10.

Thierry Jo Molina, Danielle Canioni, and Jean-Philippe Jais, Assistance Publique-Hôpitaux de Paris (AP-HP), Necker Enfants-Malades, Université Paris Descartes, EA 7324, Sorbonne Paris Cité; Josette Brière and Catherine Thieblemont, AP-HP, Saint-Louis, Université Paris Diderot, Sorbonne Paris Cité; Catherine Thieblemont, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U728; Bettina Fabiani, AP-HP, Saint-Antoine, Paris; Christiane Copie-Bergman, Corinne Haioun, Karen Leroy, and Philippe Gaulard, AP-HP, Groupe Hospitalier Henri-Mondor/Albert-Chenevier, Université Paris-Est Créteil; Christiane Copie-Bergman, Karen Leroy, and Philippe Gaulard, INSERM Unité U955 Équipe 9, Créteil; Christian Recher, Centre Hospitalier Universitaire (CHU) Purpan, Université Toulouse III Paul Sabatier, Toulouse; Françoise Berger, Gilles Salles, and Bertrand Coiffier, Hospices Civils de Lyon, Université Claude Bernard, Pierre-Bénite; Christophe Fermé, Institut Gustave Roussy, Villejuif; Marie-Christine Copin and Franck Morschauser, CHU Lille, Lille; Olivier Casasnovas and Tony Petrella, CHU Dijon, Dijon; Nicolas Mounier, CHU Nice, Nice; and Fabrice Jardin and Hervé Tilly, Centre Henri Becquerel, Université de Rouen, Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.9493DOI Listing
December 2014

Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma.

Eur J Nucl Med Mol Imaging 2014 Nov 26;41(11):2023-30. Epub 2014 Jun 26.

AP-HP- Hôpital Européen Georges Pompidou, Service de médecine nucléaire, Paris, 75015, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-014-2825-4DOI Listing
November 2014

Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia.

Br J Haematol 2014 Aug 18;166(3):390-400. Epub 2014 Apr 18.

Caen University Hospital, Laboratory of Haematology, Caen, France; University of Caen, Medical School, EA4652, Caen, France; Caen University Hospital, Regional Registry of Malignant Haemopathies of Lower-Normandy, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12908DOI Listing
August 2014

Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.

J Clin Oncol 2014 May 31;32(13):1338-46. Epub 2014 Mar 31.

Eva Hoster, Roswitha Forstpointner, Wolfgang Hiddemann, Martin H. Dreyling, and Michael Unterhalt, University Hospital Munich; Eva Hoster, University of Munich, Munich; Wolfram Klapper, University of Kiel; Christiane Pott, University Hospital Schleswig-Holstein, Kiel; Michael Hallek, Universität Köln, Köln; Stephan Stilgenbauer, University of Ulm, Ulm, Germany; Olivier Hermine, University Paris Descartes and Université Sorbonne Paris Cité; Catherine Thieblemont, Hôpital Saint Louis, Paris; Vincent Ribrag, Institut Gustave Roussy, Villejuif, France; Hanneke C. Kluin-Nelemans, University of Groningen, Groningen; Jeanette Doorduijn, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Jan Walewski and Michal Szymczyk, Maria Sklodowska-Curie Memorial Institute, Warsaw, Poland; Achiel van Hoof, A. Z. Sint Jan AV, Brugge, Belgium; Marek Trneny, Charles University General Hospital, Prague, Czech Republic; Christian H. Geisler, Rigshospitalet, Copenhagen, Denmark; and Francesco Di Raimondo, University of Catania, Italy.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/03/28/JCO.2013.52
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.52.2466
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.52.2466DOI Listing
May 2014

Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.

Br J Haematol 2014 Mar 11;164(6):896-9. Epub 2013 Dec 11.

Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland; Division of Haematology, Azienda Ospedaliera S. Maurizio, Bolzano/Bozen, Italy; Department Haematology & Oncology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12688DOI Listing
March 2014

Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type.

Semin Cancer Biol 2014 Feb 9;24:33-42. Epub 2013 Dec 9.

San Raffaele Scientific Institute, Unit of Lymphoid Malignancies, Milano, Italy; San Raffaele Scientific Institute, Pathology Unit, Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2013.11.005DOI Listing
February 2014

At diagnosis, diffuse large B-cell lymphoma patients show impaired rituximab-mediated NK-cell cytotoxicity.

Eur J Immunol 2013 May 11;43(5):1383-8. Epub 2013 Mar 11.

Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Service d'Hématologie-Oncologie Adulte, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201242733DOI Listing
May 2013

MYC, BCL2, BCL6 in DLBCL: impact for clinics in the future?

Blood 2013 Mar;121(12):2165-6

AP-HP-Hopital Saint-Louis, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-01-480392DOI Listing
March 2013

Lenalidomide in diffuse large B-cell lymphoma.

Adv Hematol 2012 20;2012:861060. Epub 2012 Nov 20.

Hematology and Oncology Department, Hôpital Saint-Louis, AP-HP and IUH, INSERM U728, University Paris VII, 75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/861060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508519PMC
December 2012

Therapy-related classical Hodgkin lymphoma after a primary haematological malignancy: a report on 13 cases.

Br J Haematol 2012 Sep 26;158(5):644-8. Epub 2012 Jun 26.

Department of Haemato-Oncology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris 7-Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2141.2012.09202.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2012.09202.xDOI Listing
September 2012